1[1]Harker LA, Mann KG, Thrombosis and Fibrinolysis. In: Fuster V, Verstraete M, eds. Thrombosis in cardiovascular disorders. Philadephia: WB Saunders 1992,1 ～ 16.
2[2]Francis CW, Conagham DG, Scott WL, et al. Increased plasma concentrations of corss-linked fibrin polymers in acute myocardial infarction. Circulation,1987,75(6): 1170 ～ 1176.
3[3]Francis CW, Kormberg A. Fibrinogen and fibrin degradation products during fibrinolytic therapy. Annals of the New York Academy of Sciences, 1993,667,310 ～ 323.
4[4]Bauer K, Rosenberg R. The pathophysiology of the prethrombotic state in humans: insight gained from studied using markers of heamostatic system activation. Blood, 1987,70:343 ～ 350.
5[5]Steveson R. AMI diagnosis could save billions. AACC National Meeting Workshop, Chicago, IL, 1992,28 ～ 33.
6[6]David GM. Carville thrombus precursor protein(TpP): marker of thrombosis early in the pathogenesis of myocardial infarction. Clinical Chemistry, 1956,429:1537 ～ 1541.
7[7]Wieding JU, Hosius C. Determination of soluble fibrin: a comparison of tour different methods. Thrombosis Research, 1992,65:745 ～ 746.
8[8]Rosenfeld BA, Carville DGM, Dimitrijevic N, et al. The determination of soluble fibrin polymers in surgical patients. Thrombosis & Haemostasis. 1995,73: 227.
9[9]Oliby JD, Lin BL, Turco MA, et al. A method for monitoring formation of arterial thrombosis during PTCA patient. Submitted for Publication.
10[10]Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute infarction necessitates the need for a new diagnosis mind-set. Circulation, 1994,89:872～881.
